rhodioloside has been researched along with Adenocarcinoma of Lung in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, M; Jin, G; Ma, M; Yang, C; Zhen, L | 1 |
1 other study(ies) available for rhodioloside and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Salidroside suppresses the multiple oncogenic activates and immune escape of lung adenocarcinoma through the circ_0009624-mediated PD-L1 pathway.
Topics: Adenocarcinoma of Lung; B7-H1 Antigen; Cell Line, Tumor; Cell Proliferation; Glucosides; Humans; Lung Neoplasms | 2023 |